Girish Dhall, Md
Clinical trials sponsored by Girish Dhall, Md, explained in plain language.
-
Can a Two-Drug combo stop a rare, aggressive nerve tumor?
Disease control Not yet recruitingThis phase 2 trial is testing whether the combination of avutometinib and defactinib can stop or shrink malignant peripheral nerve sheath tumors (MPNST) that have returned or cannot be removed with surgery. The study enrolls people over 12 years old with relapsed, refractory, met…
Phase: PHASE2 • Sponsor: Girish Dhall, MD • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug cocktail aims to shrink NF1 tumors
Disease control Not yet recruitingThis early-stage trial tests whether two cancer drugs, cabozantinib and selumetinib, can safely shrink plexiform neurofibromas in people aged 16 and older with neurofibromatosis type 1 (NF1). About 30 participants will receive the combination daily. The study first finds the safe…
Phase: PHASE1 • Sponsor: Girish Dhall, MD • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC